IGF1R and neoplasm: Exposure to TKI therapy has been associated with amplification of receptors and growth factors including insulin growth factor receptor (IGFR), fibroblast growth factor receptors (FGFRs), platelet-derived growth factor receptors (PDGFRs), and vascular endothelial growth factor (VEGF), all of which promote tumor cell proliferation and tumor blood supply [29].